Tempest Therapeutics
BiotechnologySan Francisco, California, United StatesPost-IPO Equity$107.0M total fundingwww.tempesttx.com
Latest funding:$2.0M · Post-IPO Equity (May 29, 2026)
Angel investors who backed Tempest Therapeutics
26 investors in our database backed Tempest Therapeutics.
Luke Bagaason, CFA
Manager - Portfolio Valuation
Dennis Ryan
Chief Financial Officer & Managing Director
Dorothy Margolskee
Managing Director
Richard Lau, CFA
Partner
Brian Atwood
Founder, CEO
Charles Warden
Managing Director
Ross Jaffe
Managing Director
Fei Chen
Managing Partner
Yi Shi
Founding Managing Partner
Ling Su
Venture Partner
Gavin Xia
Venture Partner
Judith Li
Partner
Joel Drewry
Principal
Robin Praeger
Managing Director/Advisor
Bill Link
investor
Don Milder
Managing Partner
Beckie Robertson
Founder and General Partner
Barbara Lubash
Managing Director (Emeritus) and Co-Founder
Rachel Lane PhD
Chief Business Officer
guido magni
Partner ,Versant Ventures
Clare Ozawa
Managing Director
Brad Bolzon
Chairman, Managing Director
Alexander Mayweg
Managing Director
Paul Grayson
Partner
Fang Ni
Principal
Tom Woiwode
Managing Director
Versant Ventures
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Tempest Therapeutics.
Search investors